Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-005308
Filing Date
2021-01-19
Accepted
2021-01-19 16:05:21
Documents
4
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212211d2_def14a.htm DEF 14A 109125
2 GRAPHIC image_001.jpg GRAPHIC 9053
3 GRAPHIC proxycard_001.jpg GRAPHIC 65433
4 GRAPHIC proxycard_002.jpg GRAPHIC 59907
  Complete submission text file 0001104659-21-005308.txt   295772
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 21535505
SIC: 2834 Pharmaceutical Preparations